skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma

Journal Article · · Medical and Pediatric Oncology; (United States)

Two patients with brain stem gliomas were treated with hyperfractionated radiation therapy (HFR) (7,020 and 7,560 cGy, respectively). Despite initial clinical improvement during irradiation, both patients demonstrated clinical deterioration approximately 3 weeks after completion of radiotherapy. Cranial magnetic resonance imaging (MRI) revealed a progressive increase in distribution of abnormal brain stem signal consistent with either tumor or edema. {sup 18}FDG positron emission tomography (PET) was obtained in one patient and demonstrated a hypermetabolic lesion at diagnosis and a hypometabolic lesion at the time of clinical deterioration postirradiation. Management with a tapering dose of dexamethasone alone resulted in marked clinical (both patients) and radiographic (one patient) improvement, allowing reduction or discontinuation of this medication. These results suggest that patients with brain stem tumors demonstrating clinical and radiographic evidence of progressive tumor shortly after completion of HFR should be initially managed conservatively with dexamethasone, since these findings may be manifestations of reversible radiation-related neurotoxicity.

OSTI ID:
5396865
Journal Information:
Medical and Pediatric Oncology; (United States), Vol. 19:3; ISSN 0098-1532
Country of Publication:
United States
Language:
English

Similar Records

Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET
Journal Article · Sat Dec 01 00:00:00 EST 1990 · Radiology; (USA) · OSTI ID:5396865

Comparison of thallium 201 (TL) SPECT and F-18 fluoro-deoxyglucose (FDG) PET in the evaluation of MRI lesions in patients with gliomas after therapy
Journal Article · Sun May 01 00:00:00 EDT 1994 · Journal of Nuclear Medicine · OSTI ID:5396865

Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21
Journal Article · Fri Nov 07 00:00:00 EST 2014 · Biochemical and Biophysical Research Communications · OSTI ID:5396865